COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 3.240
+0.240 (8.00%)
Jun 30, 2026, 3:16 PM EST
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 10.32 million as of July 1, 2026. Its market cap has decreased by -33.90% in one year.
Market Cap
10.32M
Enterprise Value
6.15M
Revenue
11.17M
Ranking
n/a
PE Ratio
1.82
Stock Price
3.24
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 14.82B to 10.32M, a decrease of -99.93%. That is a compound annual growth rate of -21.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 10.32M | 14.12% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 15.24M |
| Rapid Dose Therapeutics | 12.28M |
| Britannia Life Sciences | 12.17M |
| Hemostemix | 10.88M |
| Marvel Biosciences | 9.77M |
| PreveCeutical Medical | 9.18M |
| Glow Lifetech | 8.66M |
| Kane Biotech | 6.15M |